Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Emerging role of interleukin-22 in autoimmune diseases.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
[Vitamin D and neurology.]
The essential role of t cells in multiple sclerosis: A reappraisal.
Gait variability and multiple sclerosis.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Similar genetics of adult and pediatric MS: Age is just a number.
Computer-based diagnosis of illness in historical persons.
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Endothelial microparticles interact with and support the proliferation of T cells.
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity using Multi-Target Docking.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.

Pages